BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hester J, Ventetuolo C, Lahm T. Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure. Compr Physiol 2019;10:125-70. [PMID: 31853950 DOI: 10.1002/cphy.c190011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Morty RE. World health days in May 2020: pulmonary hypertension; asthma; and tobacco-, smoking-, and vaping-related disease in focus. Am J Physiol Lung Cell Mol Physiol 2020;318:L988-91. [PMID: 32233790 DOI: 10.1152/ajplung.00115.2020] [Reference Citation Analysis]
2 Pana TA, Dawson DK, Mohamed MO, Murray F, Fischman DL, Savage MP, Mamas MA, Myint PK. Sex Differences in Ischemic Stroke Outcomes in Patients With Pulmonary Hypertension. J Am Heart Assoc 2021;10:e019341. [PMID: 33682439 DOI: 10.1161/JAHA.120.019341] [Reference Citation Analysis]
3 Nie C, Zhu C, Xiao M, Lu Z, Yang Q, Meng Y, Wu R, Wang S. Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. Front Cardiovasc Med 2021;8:666431. [PMID: 34307491 DOI: 10.3389/fcvm.2021.666431] [Reference Citation Analysis]
4 Ge X, Zhu T, Zhang X, Liu Y, Wang Y, Zhang W. Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis. Respir Res 2020;21:44. [PMID: 32028950 DOI: 10.1186/s12931-020-1309-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Sadowska O, Baranowska-Kuczko M, Gromotowicz-Popławska A, Biernacki M, Kicman A, Malinowska B, Kasacka I, Krzyżewska A, Kozłowska H. Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Int J Mol Sci 2020;21:E7077. [PMID: 32992900 DOI: 10.3390/ijms21197077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kariotis S, Jammeh E, Swietlik EM, Pickworth JA, Rhodes CJ, Otero P, Wharton J, Iremonger J, Dunning MJ, Pandya D, Mascarenhas TS, Errington N, Thompson AAR, Romanoski CE, Rischard F, Garcia JGN, Yuan JX, An TS, Desai AA, Coghlan G, Lordan J, Corris PA, Howard LS, Condliffe R, Kiely DG, Church C, Pepke-Zaba J, Toshner M, Wort S, Gräf S, Morrell NW, Wilkins MR, Lawrie A, Wang D; UK National PAH Cohort Study Consortium. Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nat Commun 2021;12:7104. [PMID: 34876579 DOI: 10.1038/s41467-021-27326-0] [Reference Citation Analysis]
7 Yang Y, Lin F, Xiao Z, Sun B, Wei Z, Liu B, Xue L, Xiong C. Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update. Biomedicine & Pharmacotherapy 2020;129:110355. [DOI: 10.1016/j.biopha.2020.110355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kostyunina DS, McLoughlin P. Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes. Antioxidants (Basel) 2021;10:779. [PMID: 34068984 DOI: 10.3390/antiox10050779] [Reference Citation Analysis]
9 Prisco SZ, Thenappan T, Prins KW. Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. JACC Basic Transl Sci 2020;5:1244-60. [PMID: 33426379 DOI: 10.1016/j.jacbts.2020.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. Sex Differences in Portopulmonary Hypertension. Chest 2021;159:328-36. [PMID: 32798521 DOI: 10.1016/j.chest.2020.07.081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Babicheva A, Makino A, Yuan JX. mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. Int J Mol Sci 2021;22:2144. [PMID: 33670032 DOI: 10.3390/ijms22042144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shimoda LA. Know your enemy: understanding the pathophysiology of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2020;318:L995-7. [PMID: 32233788 DOI: 10.1152/ajplung.00111.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ribon-Demars A, Jochmans-Lemoine A, Ganouna-Cohen G, Boreau A, Marcouiller F, Bairam A, Pialoux V, Joseph V. Lung oxidative stress and transcriptional regulations induced by estradiol and intermittent hypoxia. Free Radic Biol Med 2021;164:119-29. [PMID: 33385539 DOI: 10.1016/j.freeradbiomed.2020.12.433] [Reference Citation Analysis]
14 Ballard W 3rd, Dixon B, McEvoy CA, Verma AK. Pulmonary Arterial Hypertension in Pregnancy. Cardiol Clin 2021;39:109-18. [PMID: 33222807 DOI: 10.1016/j.ccl.2020.09.007] [Reference Citation Analysis]
15 Vallabhajosyula S, Verghese D, Desai VK, Sundaragiri PR, Miller VM. Sex differences in acute cardiovascular care: a review and needs assessment. Cardiovasc Res 2021:cvab063. [PMID: 33734314 DOI: 10.1093/cvr/cvab063] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Walsh TP, Baird GL, Atalay MK, Agarwal S, Arcuri D, Klinger JR, Mullin CJ, Morreo H, Normandin B, Shiva S, Whittenhall M, Ventetuolo CE. Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial. Pulm Circ 2021;11:2045894021989554. [PMID: 34094503 DOI: 10.1177/2045894021989554] [Reference Citation Analysis]
17 Takase T, Taniguchi M, Hirano Y, Nakazawa G, Miyazaki S, Iwanaga Y. Sex difference in pulmonary hypertension in the evaluation by exercise echocardiography. Pulm Circ 2021;11:2045894020988453. [PMID: 33614017 DOI: 10.1177/2045894020988453] [Reference Citation Analysis]
18 Cirulis MM, Dodson MW, Brown LM, Brown SM, Lahm T, Elliott G. At the X-Roads of Sex and Genetics in Pulmonary Arterial Hypertension. Genes (Basel) 2020;11:E1371. [PMID: 33233517 DOI: 10.3390/genes11111371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 de Man FS, Naeije R. Sex and the Right Ventricle in Heart Failure With Preserved Ejection Fraction. Chest 2021;159:2156-8. [PMID: 34099128 DOI: 10.1016/j.chest.2021.02.001] [Reference Citation Analysis]
20 Shang X, Zhang C, Liu M, Lu R, Wang Y. Right ventricular contractility as a potential independent evaluation parameter in pulmonary hypertension. Int J Clin Pract 2021;75:e14183. [PMID: 33768650 DOI: 10.1111/ijcp.14183] [Reference Citation Analysis]
21 Yu Z, Xiao J, Chen X, Ruan Y, Chen Y, Zheng X, Wang Q. Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00568-w] [Reference Citation Analysis]
22 Baird GL, Walsh T, Aliotta J, Allahua M, Andrew R, Bourjeily G, Brodsky AS, Denver N, Dooner M, Harrington EO, Klinger JR, MacLean MR, Mullin CJ, Pereira M, Poppas A, Whittenhall M, Ventetuolo CE. Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension. Ann Am Thorac Soc 2021;18:218-28. [PMID: 32885987 DOI: 10.1513/AnnalsATS.202006-671OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Al-Naamani N, Ventetuolo CE. Another Piece in the Estrogen Puzzle of Pulmonary Hypertension. Am J Respir Crit Care Med 2020;201:274-5. [PMID: 31689368 DOI: 10.1164/rccm.201910-1982ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Santiago-Vacas E, García-Lunar I, Solanes N, Dantas AP, Ascaso M, Jimenez-Trinidad FR, Ramirez J, Fernández-Friera L, Galán C, Sánchez J, Sabaté M, Pérez-Villa F, Rigol M, Pereda D, Ibañez B, García-Álvarez A. Effect of sildenafil on right ventricular performance in an experimental large-animal model of postcapillary pulmonary hypertension. Transl Res 2021;228:64-75. [PMID: 32835905 DOI: 10.1016/j.trsl.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Austin ED. Sex Hormones across the Menstrual Cycle in Pulmonary Arterial Hypertension: Adding a New Layer of Complexity. Ann Am Thorac Soc 2021;18:209-11. [PMID: 33522875 DOI: 10.1513/AnnalsATS.202011-1379ED] [Reference Citation Analysis]
26 Chaudhary KR, Deng Y, Yang A, Cober ND, Stewart DJ. Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex. J Am Heart Assoc 2021;10:e019488. [PMID: 34315227 DOI: 10.1161/JAHA.120.019488] [Reference Citation Analysis]
27 Pooja, Sharma V, Meena RN, Ray K, Panjwani U, Varshney R, Sethy NK. TMT-Based Plasma Proteomics Reveals Dyslipidemia Among Lowlanders During Prolonged Stay at High Altitudes. Front Physiol 2021;12:730601. [PMID: 34721061 DOI: 10.3389/fphys.2021.730601] [Reference Citation Analysis]
28 Honigberg MC, Patel AP, Lahm T, Wood MJ, Ho JE, Kohli P, Natarajan P. Association of premature menopause with incident pulmonary hypertension: A cohort study. PLoS One 2021;16:e0247398. [PMID: 33690615 DOI: 10.1371/journal.pone.0247398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Tang C, Luo Y, Li S, Huang B, Xu S, Li L. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Biomed Pharmacother 2021;133:111081. [PMID: 33378977 DOI: 10.1016/j.biopha.2020.111081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Nardiello C, Morty RE. World health observances in September 2020: sepsis, the lung and heart, and pulmonary fibrosis in focus. Am J Physiol Lung Cell Mol Physiol 2020;319:L513-7. [PMID: 32783623 DOI: 10.1152/ajplung.00375.2020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Labazi H, Axelsen JB, Hillyard D, Nilsen M, Andersen A, MacLean MR. Sex-Dependent Changes in Right Ventricular Gene Expression in Response to Pressure Overload in a Rat Model of Pulmonary Trunk Banding. Biomedicines 2020;8:E430. [PMID: 33086482 DOI: 10.3390/biomedicines8100430] [Reference Citation Analysis]
32 Amgoud Y, Senbel A, Bouhadoun A, Abdelazeem H, Ozen G, Savané I, Manikpurage HD, Mani S, Tran-Dinh A, Castier Y, Guyard A, Longrois D, Silverstein AM, Norel X. In search of pulmonary hypertension treatments: Effect of 17β-estradiol on PGI2 pathway in human pulmonary artery. Prostaglandins Leukot Essent Fatty Acids 2021;172:102321. [PMID: 34403986 DOI: 10.1016/j.plefa.2021.102321] [Reference Citation Analysis]
33 Liu MN, Luo G, Gao WJ, Yang SJ, Zhou H. miR-29 family: A potential therapeutic target for cardiovascular disease. Pharmacol Res 2021;166:105510. [PMID: 33610720 DOI: 10.1016/j.phrs.2021.105510] [Reference Citation Analysis]
34 Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais MC, Jaïs X, Bertoletti L, Sitbon O, Weatherald J, Humbert M, Montani D. Sex and gender in pulmonary arterial hypertension. Eur Respir Rev 2021;30:200330. [PMID: 34750113 DOI: 10.1183/16000617.0330-2020] [Reference Citation Analysis]
35 Qin S, Predescu D, Carman B, Patel P, Chen J, Kim M, Lahm T, Geraci M, Predescu SA. Up-Regulation of the Long Noncoding RNA X-Inactive-Specific Transcript and the Sex Bias in Pulmonary Arterial Hypertension. Am J Pathol 2021;191:1135-50. [PMID: 33836164 DOI: 10.1016/j.ajpath.2021.03.009] [Reference Citation Analysis]